In this study, we demonstrated that local production of MIP-3α by NDV-MIP3α injection in the tumor tissues could induce the intratumoral accumulation of DCs with a stronger tumor-specific CTL and antibody response and more significant suppression of tumor growth without ex vivo manipulation of DCs. The gene discussed is CCL20; the disease is neoplasm.